NXGL
NEXGEL, Inc.NASDAQHealthcare$0.59+10.02%ClosedMarket Cap: $6.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.15
P/S
0.61
EV/EBITDA
-2.86
DCF Value
$-306.54
FCF Yield
-18.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
39.5%
Operating Margin
-29.3%
Net Margin
-26.3%
ROE
-61.5%
ROA
-28.7%
ROIC
-42.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $2.8M | 29.3% | $-1.2M | $-970.0K | $-0.12 | — |
| FY 2025 | $11.4M | 39.5% | $-3.4M | $-3.0M | $-0.38 | — |
| Q3 2025 | $2.9M | 42.4% | $-725.0K | $-653.0K | $-0.08 | — |
| Q2 2025 | $2.9M | 43.6% | $-636.0K | $-665.0K | $-0.09 | — |
| Q1 2025 | $2.8M | 42.3% | $-777.0K | $-712.0K | $-0.09 | — |
| Q4 2024 | $3.0M | 25.6% | $-841.0K | $-850.0K | $-0.12 | — |
| FY 2024 | $8.7M | 31.6% | $-3.6M | $-3.3M | $-0.50 | — |
| Q3 2024 | $2.9M | 43.6% | $-788.0K | $-693.0K | $-0.11 | — |
| Q2 2024 | $1.4M | 28.5% | $-1.1M | $-885.0K | $-0.14 | — |
| Q1 2024 | $1.3M | 12.6% | $-871.0K | $-853.0K | $-0.14 | — |
| Q4 2023 | $1.1M | 14.6% | $-1.2M | $-1.1M | $-0.19 | — |
| FY 2023 | $4.1M | 9.1% | $-3.5M | $-3.2M | $-0.56 | — |